ERBB2 and triple-negative breast carcinoma: According to the global histologic and IHC classification, BC is divided into four clinically relevant subtypes: luminal A, luminal B, human epidermal growth factor receptor 2 (HER2)–enriched, and triple-negative breast cancer.